Treatment of warts with immune response modifiers

British Journal of Dermatology

Volumn 143, Issue 5, 2000, Pages 921-922

  Benton, E C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CIMETIDINE; IMIQUIMOD; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; METHISOPRINOL;

CONDYLOMA; DRUG EFFICACY; EDITORIAL; HUMAN; IMMUNOMODULATION; PRECANCER; PRIORITY JOURNAL; TREATMENT OUTCOME; VERRUCA VULGARIS;

AMINOQUINOLINES; ANTIVIRAL AGENTS; HUMANS; INTERFERON INDUCERS; SKIN DISEASES; WARTS;

EID: 0033749355     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03944.x     Document Type: Editorial

References (8)

1. Cimetidine therapy for warts: A placebo-controlled, double-blind study
2. Treatment of common and plantar warts with human lymphoblastoid interferon-alpha - Pilot studies with intralesional intramuscular and dermojet injections
3. Self-administered topical 5% imiquimod for the treatment of common warts and mollusca contagiosa
4. Imiquimod 5% cream (Aldara®)
5. Treatment of genital warts with an immune-response modifier (imiquimod)
6. Self-administered topical 5% imiquimod cream for external anogenital warts
7. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
8. Imiquimod - A novel treatment for lentigo maligna